LPC 18:2-Driven Apoptosis In Neutrophils Is Non-Inflammatory and Lipid Raft Dependent
Authors:
- Priyanka SaminathanPSPriyanka Saminathan
- Alicia GibbonsAlicia Gibbons
- Ian MathewsIMIan Mathews
- Maija Y CoreyMCMaija Y Corey
- Ashmitaa LogandhaALAshmitaa Logandha
- Mahati RayadurgamMRMahati Rayadurgam
- Namratha NadigNNNamratha Nadig
- Camille FangCFCamille Fang
- Neha ReddyNRNeha Reddy
- Mousa VatanmakanianMVMousa Vatanmakanian
- Sonia SharmaSSSonia Sharma
Preprint
Abstract
Lysophosphatidylcholines (LPCs) are potent bioactive lipids whose fatty acid compositions dictate their immunomodulatory effects. Here, we delineate how unsaturated LPC 18:2 and saturated LPC 16:0 differentially regulate neutrophil survival and inflammatory programs. LPC 18:2 markedly increased reactive oxygen species (ROS) generation and caspase-3/7 activation, mitochondrial membrane depolarization, and cytochrome c release, features consistent with intrinsic apoptosis. In contrast, LPC 16:0 induced robust LDH and HMGB-1 release, indicating membrane rupture and pyroptosis-like death. Bulk RNA sequencing revealed that LPC 16:0 strongly upregulated inflammatory and cytokine gene expression. Disruption of lipid-raft integrity abolished LPC 18:2-induced ROS and apoptosis, underscoring the dependence of these effects on membrane organization. Collectively, these results identify LPC 18:2 as a non-inflammatory, mitochondria-dependent inducer of neutrophil apoptosis, whereas LPC 16:0 promotes inflammatory, lytic death programs. These findings highlight how lipid saturation determines neutrophil fate and immune tone, providing mechanistic insight into how distinct LPC species shape inflammation and tissue injury.Keywords
Funding Information
- National Institutes of Health (20071-04-403)
- National Institutes of Health (40083-01-403)
- National Institutes of Health (5T32AI125179-09)
This publication has 51 references indexed in Scilit:
- Substrate Preferences of a Lysophosphatidylcholine Acyltransferase Highlight Its Role in Phospholipid RemodelingLipids, 2008
- Discovery of a lysophospholipid acyltransferase family essential for membrane asymmetry and diversityProceedings of the National Academy of Sciences, 2008
- Lysophosphatidylcholine contents in plasma LDL in patients with type 2 diabetes mellitus: Relation with lipoprotein-associated phospholipase A2 and effects of simvastatin treatmentAtherosclerosis, 2008
- Acyl chain-dependent effect of lysophosphatidylcholine on human neutrophilsJournal of Leukocyte Biology, 2007
- Plasma Lysophosphatidylcholine Levels: Potential Biomarkers for Colorectal CancerJournal of Clinical Oncology, 2007
- Linoleoyl lysophosphatidic acid and linoleoyl lysophosphatidylcholine are efficient substrates for mammalian lipoxygenasesBiochimica et Biophysica Acta (BBA) - General Subjects, 2007
- Apoptosis: A Review of Programmed Cell DeathToxicologic Pathology, 2007
- Use of cyclodextrins to manipulate plasma membrane cholesterol content: Evidence, misconceptions and control strategiesBiochimica et Biophysica Acta (BBA) - Biomembranes, 2007
- Decreased lysophosphatidylcholine/phosphatidylcholine ratio in cerebrospinal fluid in Alzheimer?s diseaseJournal of Neural Transmission, 2003
- Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF.Journal of Clinical Investigation, 1998